ARCHIMEDlife News
-
Detect Severe combined immunodeficiency (SCID) early at birth!
ARCHIMEDlife News June 21, 2017We offer TREC (T-cell receptor excision circle) DNA testing from Dried Blood Spots to aid in screening newborns for Severe Combined Immunodeficiency (SCID). SCID is… Read more -
Correlation of Lyso-Gb3 levels in Patients with Classic and Later-Onset Fabry
Background: Fabry disease (FD), an X-linked lysosomal storage disorder, results from the deficient activity of α-galactosidase A (α-Gal A) and the accumulation of its substrates,… Read more -
Metabolic progression to clinical phenotype in classic Fabry disease
Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of Fabry disease is preceded by significant… Read more -
Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disorder due to mutations in the a-galactosidase A gene (GLA) that result in absent or markedly… Read more -
Upcoming expanded Testing for Lysosomal Storage Disorders
ARCHIMEDlife News September 21, 2016ARCHIMEDlife started offering genetic testing for Gaucher, Niemann-Pick A/B, MPS-I, Pompe and Fabry disease. More recently, we expanded our services for MPS II/ IVA and… Read more -
Homocystein and Methylmalonic acid – Novel 2nd-tier tests
ARCHIMEDlife News September 21, 2016In the healthy cell metabolism homocysteine is a short-living intermediate product, which is either transformed or removed by various metabolic pathways. The malfunction of the… Read more